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Objective: To study the changes of the rest energy expenditure, intracranial pressure,
brain function parameters and serum indexes of acute craniocerebral injury after treated
with mild hypothermia auxiliary therapy.
Methods: Clinical data of 58 patients received emergency treatment for craniocerebral
injury in our hospital from October 2009 to December 2014 were analyzed retrospec-
tively. Among them, 27 cases treated with mild hypothermia therapy were included in the
experiment group, while 31 cases without the therapy were considered as the control
group. Their rest energy expenditure, intracranial pressure, brain function parameters and
serum TNF-a, nitric oxide and myelin basic protein contents were determined.
Results: The intracranial pressure [(20.3 ± 2.9) vs. (25.8 ± 3.3) mmHg], [(17.8 ± 2.7) vs.
(23.1 ± 3.6) mmHg], [(14.2 ± 2.4) vs. (20.6 ± 3.1) mmHg], [(11.3 ± 1.8) vs. (16.3 ± 2.6)
mmHg] and rest energy expenditure [(6861 ± 994) vs. (14074 ± 2016) kJ/d],
[(5946 ± 768) vs. (15525 ± 1936) kJ/d], [(5512 ± 873) vs. (5512 ± 873) kJ/d],
[(6248 ± 906) vs. (14413 ± 2166) kJ/d] in patients of experiment group on the 1st, 2nd,
3rd and 4th days after treatment were all signiﬁcantly lower than those of patients in the
control group. After treated for 24 h, PbtO2 [(23.59 ± 4.97) vs. (15.68 ± 3.14) mmHg] and
SjvO2 [(61.39 ± 9.79) vs. (46.76 ± 7.28) %] of the experiment group were distinctly
higher than those of the control group, while its contents of TNF-a [(1.96 ± 0.29) vs.
(3.39 ± 0.72) mg/L] and nitric oxide [(10.39 ± 2.16) vs. (24.42 ± 3.51) mg/L] and myelin
basic protein [(2.19 ± 0.52) vs. (4.34 ± 0.78) mg/L] were all lower than those of the
control group.
Conclusions: After treated with mild hypothermia auxiliary therapy, the metabolic rate
and intracranial pressure of patients with craniocerebral injury decreased obviously, their
cerebral blood ﬂow perfusion were improved evidently and the release of adverse
metabolic products were also reduced conspicuously, which was beneﬁcial to the re-
covery of neurological functions.1. Introduction
Craniocerebral injury is a common and dangerous disease.
Trauma-caused intracranial hematoma, brain edema, increased
ICP and cerebral hernia will lead to nerve function impairment.
The disease is serious and rapid developed and also its disabilityrate and fatality rate are pretty high[1,2]. The main principles for
treating sever craniocerebral injury are emergency rescue,
correction of shock, craniotomies decompression and anti-
infection[3,4]. Continuous increased intracranial pressure (ICP)
is an important factor causing irreversible damage of
neurological function for patients with craniocerebral trauma.
Meanwhile, after the occurrence of trauma, the high metabolic
state of craniocerebral tissues would consume more oxygen
and inﬂuence the recovery of neurological function. It
becomes an important issue that how to decrease ICP,
maintain intracranial environmental stability and reduce brain
metabolism and oxygen consumption reasonably and
scientiﬁcally[5–7]. Mild hypothermia is a ﬁrst aid measure for
craniocerebral injury which was developed in recent years.e under the CC BY-NC-ND license (http://
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32–35 C can inhibit the metabolism of the brain cells and
oxygen consumption, reduce production of harmful substance
produced in the traumatic acute phase, relieve brain edema,
and decrease ICP[8,9]. In the following studies, the changes of
the rest energy expenditure, ICP, brain function parameters
and serum indexes of craniocerebral injury after treated with
mild hypothermia auxiliary therapy were analyzed.Table 1
General clinical data of patients in the experiment group and the control
group.





Gender (male/female) 19/8 22/9 >0.05
Age (year) 38.1 ± 6.5 36.3 ± 6.9 >0.05
GCS score 6.2 ± 0.9 6.5 ± 0.8 >0.05
ALT (IU/L) 38.5 ± 6.1 39.8 ± 6.4 >0.05
AST (IU/L) 45.2 ± 7.9 43.5 ± 7.5 >0.05
Scr (mmol/L) 75.1 ± 10.8 76.3 ± 11.2 >0.05
BUN (mmol/L) 5.6 ± 0.9 5.9 ± 0.8 >0.052. Materials and methods
2.1. Clinical materials
A total of 58 patients received emergency treatment for
craniocerebral injury in our hospital from October 2009 to
December 2014 were analyzed retrospectively. The inclusion
criteria concluded: patients have a speciﬁc history of trauma;
patients were sent to the emergency department within 3 h after
trauma; patients' Glasgow Coma Scale (GCS) scores were lower
than 8 when admitted to hospital; patients conform to the in-
dications of decompressive craniectomy. Patients suffer serious
trauma on thorax and abdomen, and complicate with arrhythmia,
cardiovascular disease and diabetes were excluded. The causes
of traumas of the 58 cases were described below: 39 cases were
caused by trafﬁc accidents, 14 cases by falling, and 5 cases by
hitting. They were given water deprivation, hemostasis and anti-
inﬂammation therapies as soon as they admitted to the Emer-
gency Department, and surgery was prepared and inspected at
the same time. After that, patients were treated with bone disc
decompression surgery.
Among those 58 included cases, 27 of them were treated with
mild hypothermia therapy. The speciﬁc methods were described
as follows. Ice hats and ice blanket machines were use to lower
the temperature. Ice bags were placed on the superﬁcial areas of
femoral and axillary artery to decrease the anal temperature at
32–35 C within 8 h. Lyric cocktail, muscle relaxant, 100 mg
atracurium, 50 mg chlorpromazine, and 50 mg promethazine
were added together into 500 mL normal saline for intravenous
infusion. The mild hypothermia would be maintained persis-
tently for 24 h after the ICP returned to normal. After that, they
were rewarmed. The ice hats were taken away ﬁrstly, and then
ice blanket machines were removed 8 h later, meanwhile, the
used of lyric cocktail was reduced gradually. The proper speed
of rewarming should be 1 C/6 h.Table 2
Changes of the ICP in patients of the two groups before and after treat-
ment (mmHg).





Before treatment 28.9 ± 3.4 29.2 ± 4.1 >0.05
1 day after treatment 20.3 ± 2.9 25.8 ± 3.3 <0.05
2 days after treatment 17.8 ± 2.7 23.1 ± 3.6 <0.05
3 days after treatment 14.2 ± 2.4 20.6 ± 3.1 <0.05
3 days after treatment 11.3 ± 1.8 16.3 ± 2.6 <0.052.2. Study methods
The resting energy expenditure (REE) of patients was tested by
the followingmethods. The 1st, 2nd, 3rd, 4th days before and after
treatment, the oxygen consumption (VO2) and amount of carbon
dioxide exhaled (VCO2) in unit timewere determined bymetabolic
cart, REE (kJ/d) = (3.9 × VO2 + 1.1 × VCO2 ) × 1.44 × 4.18.
Brain function parameters were acquired by the following
methods. Intellivue Mp30 system (Philip company) was used to
monitor the ICP on the 1st, 2nd, 3rd, 4th days before and after
treatment by brain hydraulic transmission method. After treated
with mild hypothermia therapy for 24 h, brain tissue oxygen
pressure (PbtO2) was detected by the cerebral oxygen brain tem-
perature monitoring instrument, and the jugular vein bulb (SjvO2)
was tested by Nova-H monitoring instrument. After treated with
mild hypothermia therapy for 24 h, peripheral venous blood wascollected and the contents of TNF-a, nitric oxide and myelin basic
protein (MBP) were measured by ELISA kits.
2.3. Statistical methods
SPSS 19.0 was employed to input and analyze data. Mea-
surement data were expressed by mean ± SD and tested by t-test.
While enumeration data were presented by frequency and
determined by Chi-square test. Differences were considered
statistically signiﬁcant when P < 0.05.
3. Results
3.1. General data of patients with craniocerebral injury
of the two groups
Among those 58 included cases, 27 of them were treated with
mild hypothermia therapy. They were included in the experiment
group which consisted of 19 males and 8 females aging from
(38.1 ± 6.5) years with GCS scores of (6.2 ± 0.9), glutamic-
pyruvic transaminase (ALT) [(38.5 ± 6.1) IU/L], glutamic oxal-
acetic transaminase (AST) (45.2 ± 7.9) IU/L, serum creatinine
(SCr) [(75.1 ± 10.8) mmol/L] and blood urea nitrogen (BUN)
[(5.6 ± 0.9) mmol/L]. The rest of 31 cases who were not treated
with mild hypothermia therapy were regarded as the control
group which included 22 males and 9 females aging from
(36.3 ± 6.9) years with GCS scores of (6.5 ± 0.8), ALT
[(39.8 ± 6.4) IU/L], AST [(43.5 ± 7.5) IU/L], SCr [(76.3 ± 11.2)
mmol/L] and BUN [(5.9 ± 0.8) mmol/L]. The age, gender, GCS
score, ALT, AST, Scr and BUN showed no differences (Table 1).3.2. Changes of the ICP in patients of the two groups
before and after treatment
Before treatment, the ICP [(28.9 ± 3.4) vs. (29.2 ± 4.1) mmHg]
of patient in the experiment group had no signiﬁcant differences as
compare to that of the control group. The ICPs on the 1st, 2nd, 3rd
and 4th days of patients in the experiment groupwere all obviously
lower than those of in the control group (Table 2).
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treatment
Before treatment, the REE [(13347 ± 1935) vs.
(13713 ± 1879) kJ/d] of patient in the experiment group had no
signiﬁcant differences as compare to that of the control group.
The REE on the 1st, 2nd, 3rd and 4th days after treatment of
patients in the experiment group were all signiﬁcantly lower than
those of patients in the control group (Table 3).Table 3
Changes of REE in patients of two groups before and after treatment (kJ/
d).





Before treatment 13347 ± 1935 13713 ± 1879 > 0.05
1 day after treatment 6861 ± 994 14074 ± 2016 < 0.05
2 days after treatment 5946 ± 768 15525 ± 1936 < 0.05
3 days after treatment 5512 ± 873 14759 ± 1813 < 0.05
3 days after treatment 6248 ± 906 14413 ± 2166 < 0.053.4. The brain function parameters and serum indexes in
patients of the two groups before and after treatment
After treated for 24 h, PbtO2 and SjvO2 of the experiment
group were distinctly higher than those of the control group,
while its contents of TNF-a and nitric oxide and MBP were all
lower than those of the control group (Table 4).Table 4
The brain function parameters and serum indexes in patients of the two






PbtO2 (mmHg) 23.59 ± 4.97 15.68 ± 3.14 < 0.05
SjvO2 (%) 61.39 ± 9.79 46.76 ± 7.28 < 0.05
TNF-a (mg/L) 1.96 ± 0.29 3.39 ± 0.72 < 0.05
Nitric oxide (mg/L) 10.39 ± 2.16 24.42 ± 3.51 < 0.05
MBP (mg/L) 2.19 ± 0.52 4.34 ± 0.78 < 0.054. Discussion
Craniocerebral injury is a kind of trauma with high disability
rate and fatality rate, and about 22% patients with severe
craniocerebral injury become severely disabled, in which 5%
develop into the vegetative state and 40% die[10,11].
Craniocerebral tissues stay in a high metabolic state after
suffering from external trauma. The oxygen consumption of
brain tissues is massive and many adverse metabolic products
are produced, which, on the one hand, injures cell functions,
hinders the recovery of nerve functions, and causes cell-
derived edema as well[12,13]. On the other hand, the
accumulation of the local metabolites will change the vascular
permeability and results in vascular edema[13–15]. Patients with
craniocerebral injury commonly suffer from pathological states
such as brain tissue edema and increased ICP, which would
increase the risks of the development of the disease and the
increase of cerebral hernia if it is not treated in time, and thencause the deterioration of nerve function and affect the
outcome and prognosis of the disease. The clinical treatment
measures for craniocerebral injury include debridement,
correction of shock, craniotomies decompression and the
dehydration of ICP, which can relieve the high ICP-caused
nerve function injury. However, because the states of high
brain tissue metabolism and oxygen consumption cannot be
corrected in etiological consideration, and the adverse metabolic
products are continuously produced, brain edema will persist for
a long time. The prognosis of patients was poor, and the disease
has high disability rate and fatality rate.
Mild hypothermia therapy is a newly developed way for
treating craniocerebral trauma in recent years, which intends to
decrease the basic metabolic rate and oxygen consumption of
brain tissues and reduces the release of toxic byproducts so as to
relieve edema and decreases ICP by maintaining the body
temperature at 32–34 C[16–18]. After trauma, the increase of the
basic metabolic rate of brain tissues becomes a major
important for brain tissue edema and high ICP. The value of
mild hypothermia therapy is to reduce metabolic rate and
oxygen consumption by decreasing the temperature of the
local tissues and therefore alleviate cell-derived edema and
vascular edema and decrease high ICP[16,19–20]. After treatment,
the levels of REE and ICP were analyzed. It was found that
the mean REE and ICP of the 1st, 2nd, 3rd and 4th days in
patients of experimental group were all lower than those in the
control group, which indicated that mild hypothermia therapy
could reduce basic metabolic rate by decreasing body
temperature so as to beneﬁt for the decline of ICP level.
Despite all this, since there were individual differences
existing among individuals and the degrees of metabolism of
patients were different, the stability range of the therapy
should be designed in accordance with the individual
differences, so as to ensure that the basic metabolic rate of
those patients can be maintained in a stable range.
After trauma, the high metabolic rate and oxygen consump-
tion of brain tissues will lead to hypoxia environment in local
area. And along with the oppression of edema caused by
external trauma, the blood perfusion of brain tissues will be
affected and the brain tissue hypoxia will be aggravated as
well[21–23]. The oxygen consumption of local brain tissues and
blood perfusion condition were reﬂected by analyzing the
PbtO2 and jugular venous saturation. The results were
described as follows. The PbtO2 and SjvO2 of patients in
experiment group were all higher than that in control group,
which manifested that under mild hypothermia therapy the
oxygen consumption of brain tissues was decreased
signiﬁcantly and the blood perfusion and oxygen supply
conditions were improved obviously. Under a high-metabolic
state, brain tissues will release multiple toxic metabolites and
cause nerve injure. The levels of TNF-a and nitric oxide were
proved to be related to brain tissue injure. The former causes
injures mainly by inﬂammatory responses[24,25], while the latter
causes injures primarily by the form of free radicals on local
tissues[26,27]. In addition, when the neuron and gliocytes were
injured, the compound of MBP increased, which put cells in
an active state and inﬂuenced the recovery of nerve cells[28,29].
The analysis of the related serum biochemical indexes
conﬁrmed that the contents of serum TNF-a, nitric oxide and
MBP in patients of experimental group were signiﬁcantly
lower than those in the control group, which illustrated that
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metabolites released by brain tissues was reduced signiﬁcantly.
That was, apparently, good for the recovery of nerve functions.
To sum up, after treated with mild hypothermia auxiliary
therapy, the metabolic rate and ICP of patients with cranioce-
rebral injury was decreased obviously, and their cerebral blood
ﬂow perfusion was promoted evidently and the release of
adverse metabolic products was also reduced conspicuously,
which was beneﬁcial to the recovery of neurological functions.
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